Laboratory Testing & Practices

The following are resources of use to laboratory personnel.

Fact sheets

• Aminoglycoside Resistance in Enterobacteriaceae and Pseudomonas aeruginosa
• Quinolones and the Clinical Laboratory
• Vancomycin-resistant Enterococci (VRE) and the Clinical Laboratory

Laboratory Detection of:

• Coagulase-negative Staphylococcus species with Decreased Susceptibility to the Glycopeptides Vancomycin and Teicoplanin
• Extended-Spectrum Beta-Lactamases (ESBLs)
• Vancomycin-Intermediate/Resistant Staphylococcus aureus (VISA/VRSA)
• Imipenem or Meropenem Resistance in Gram-negative Organisms
• Oxacillin/Methicillin-resistant Staphylococcus aureus (MRSA)
• Molecular Typing of Oxacillin-resistant Staphylococcus aureus PDF (499KB / 24 pages)
• Oxacillin-resistant Coagulase-negative Staphylococcus spp.

Publications (by date)

• Laboratory Capacity to Detect Antimicrobial Resistance, 1998. MMWR 2000.
• Biosafety in Microbiological and Biomedical Laboratories; 1999.
• Staphylococcus aureus with Reduced Susceptibility to Vancomycin - U.S. MMWR 1997
• Appendix - Microscopic Procedures for Diagnosing Malaria; 1997 MMWR 1997
• Defining the public health impact of drug-resistant Streptococcus pneumoniae. Appendix. Laboratory-based surveillance system. MMWR 1996
• Recommendations for Test Performance and Interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease; MMWR 1995
• E coli O157:H7: Procedure for Isolation and Identification from Stool Specimens; MMWR 1994
• Laboratory Management of Agents Associated with Hantavirus Pulmonary Syndrome: Interim Biosafety Guidelines; MMWR 1994
• Shipping Regulations - Biomedical Materials; MMWR 1991

Infection Control Topics

• Infection Control Home
• Healthcare-Associated Infections
• Protecting Patients
• Protecting Healthcare Personnel
• Infection Control Guidelines
• Infection Control A-Z
• About DHQP